Carl Kyrklund

1.0k total citations
6 papers, 820 citations indexed

About

Carl Kyrklund is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Surgery. According to data from OpenAlex, Carl Kyrklund has authored 6 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Carl Kyrklund's work include Pharmacological Effects and Toxicity Studies (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Carl Kyrklund is often cited by papers focused on Pharmacological Effects and Toxicity Studies (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Carl Kyrklund collaborates with scholars based in Finland, Iran and Germany. Carl Kyrklund's co-authors include Pertti J. Neuvonen, Janne T. Backman, Mikko Neuvonen, Kari T. Kivistö, Thomas Lang, Matthias Schwab, Elke Schaeffeler, Reinhold Kerb, Michel Eichelbaum and Martin F. Fromm and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Contact Dermatitis.

In The Last Decade

Carl Kyrklund

6 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl Kyrklund Finland	6	404	320	315	237	93	6	820
Jenni E. Keskitalo Finland	8	440 1.1×	240 0.8×	330 1.0×	175 0.7×	89 1.0×	8	764
Hideki Fujino Japan	20	579 1.4×	508 1.6×	377 1.2×	152 0.6×	74 0.8×	36	1.1k
Teemu Kantola Finland	8	355 0.9×	538 1.7×	426 1.4×	191 0.8×	120 1.3×	10	1.2k
Lloyd R. Whitfield United States	19	325 0.8×	216 0.7×	359 1.1×	156 0.7×	85 0.9×	48	1.2k
Leslie Z. Benet United States	16	330 0.8×	308 1.0×	208 0.7×	277 1.2×	59 0.6×	26	1.0k
Ken-ichi Nezasa Japan	10	442 1.1×	299 0.9×	171 0.5×	206 0.9×	54 0.6×	12	755
Mike J. Warwick United Kingdom	12	247 0.6×	200 0.6×	485 1.5×	90 0.4×	78 0.8×	14	873
Robert Elsby United Kingdom	20	729 1.8×	551 1.7×	224 0.7×	363 1.5×	140 1.5×	25	1.6k
Annikka Kalliokoski Finland	9	710 1.8×	423 1.3×	172 0.5×	396 1.7×	139 1.5×	12	1.2k
Mark A. Milad United States	15	175 0.4×	189 0.6×	333 1.1×	115 0.5×	37 0.4×	24	966

Countries citing papers authored by Carl Kyrklund

Since Specialization

Citations

This map shows the geographic impact of Carl Kyrklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Kyrklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Kyrklund more than expected).

Fields of papers citing papers by Carl Kyrklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Kyrklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Kyrklund. The network helps show where Carl Kyrklund may publish in the future.

Co-authorship network of co-authors of Carl Kyrklund

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Kyrklund. A scholar is included among the top collaborators of Carl Kyrklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Kyrklund. Carl Kyrklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kyrklund, Carl, et al.. (2013). Allergic contact dermatitis caused by transdermal buprenorphine. Contact Dermatitis. 69(1). 60–61. 5 indexed citations

2.

Niemi, Mikko, Elke Schaeffeler, Thomas Lang, et al.. (2004). High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics. 14(7). 429–440. 326 indexed citations

3.

Kyrklund, Carl, Janne T. Backman, Mikko Neuvonen, & Pertti J. Neuvonen. (2003). Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects. British Journal of Clinical Pharmacology. 57(2). 181–187. 63 indexed citations

4.

Kyrklund, Carl. (2003). Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance. Clinical Pharmacology & Therapeutics. 73(6). 538–544. 160 indexed citations

5.

Kyrklund, Carl, Janne T. Backman, Kari T. Kivistö, et al.. (2001). Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate. Clinical Pharmacology & Therapeutics. 69(5). 340–345. 151 indexed citations

6.

Kyrklund, Carl. (2000). Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations. Clinical Pharmacology & Therapeutics. 68(6). 592–597. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact